What is the role of Tofacitinib (Janus kinase inhibitor) in the treatment of psoriatic arthritis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board

Educational purpose only • Exercise caution as content is pending human review

Article Review Status

Submitted

Under Review

Approved

Last updated: November 24, 2025 • View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Related Questions

What is the role of ixekizumab (interleukin-17A inhibitor) and tofacitinib (Janus kinase inhibitor) in the treatment of patients with psoriatic arthritis, particularly those who have failed or have contraindications to traditional disease-modifying antirheumatic drugs (DMARDs) or biologic agents?

What is the role of Janus Kinase (JAK) inhibitors, such as tofacitinib, in treating enthesitis?

Is Xeljanz (tofacitinib) effective for treating Crohn's disease and psoriatic arthritis?

What is the recommended approach for using ixekizumab (an interleukin-17A inhibitor) and tofacitinib (a Janus kinase inhibitor) in combination for a patient with psoriatic arthritis who has failed or has contraindications to traditional Disease-Modifying Antirheumatic Drugs (DMARDs) or biologic agents?

What is the recommended starting dose of Tofacitinib (Xeljanz) for a 13-year-old patient with Down syndrome associated arthritis weighing 29 kg?

What is the efficacy and safety of using Platelet-Rich Plasma (PRP) in the O-Shot for treating female sexual dysfunction?

Is ceftriaxone (Ceftriaxone) safe to use in patients with sickle cell disease (SCD) experiencing hemolysis?

Is inpatient level of care medically necessary for a patient with cervical radiculopathy and moderate to severe left and mild right foraminal stenosis undergoing C7 to T1 anterior cervical discectomy and fusion for decompression, given ambulatory status per Milliman Care Guidelines (MCG) S-320?

What are the risk factors for squamous cell carcinoma?

When should secukinumab (Cosentyx) be started in patients with moderate to severe plaque psoriasis?

Should I continue with my current diet and exercise plan to achieve my health goals?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.